Webinar
Deep Tech Fund launch
Join Matt Caspari, Managing Partner of Alumni Ventures’ Deep Tech Fund, for an introduction to one of the most consequential venture theses of the decade — and how the Deep Tech Fund gives accredited investors structured exposure to the companies solving civilization-scale technical problems across AI, biotech, space, fusion, advanced manufacturing, and the rebuild of U.S. industrial capacity.
In this session, Matt Caspari will walk through the Deep Tech Fund investment thesis and how the fund is positioned across the categories driving venture’s biggest outcomes today. Matt will share how AV identifies and evaluates deep tech companies, how the team thinks about risk and milestones in technically ambitious bets, and why deep tech has moved from venture’s hardest, slowest-moving corner to the category quietly powering some of the industry’s most consequential returns.
Whether you’re a current Alumni Ventures investor sharpening your view of the deep tech landscape, or an accredited investor evaluating the sector for the first time, this session will give you a grounded, investor-focused thesis on one of the most important shifts happening in venture today. Register to hear directly from Matt — and bring your questions to the live Q&A.
Want to access our Deep Tech Fund startup deals to see, evaluate, and optionally invest? No cost, no commitment.
Why Attend?
- HomeDiscover why deep tech has become one of venture's most consequential return drivers — and how the Deep Tech Fund is positioned across AI, biotech, space, fusion, advanced manufacturing, and U.S. industrial capacity
- HomeUnderstand how Matt and the team identify, underwrite, and build a portfolio around companies solving civilization-scale technical problems
- HomeLearn how to access this thesis through a single diversified fund, alongside accredited investors backing the frontier
Rated a Top 20 VC Firm by both TIME and CB Insights.
Alumni Ventures is America’s largest venture capital firm for individual investors.
About your presenter
Overview
Matt Caspari invests in mission-driven founders building the next generation of iconic companies—entrepreneurs tackling the world’s hardest, highest-stakes problems. He backs breakthrough technologies with the potential to redefine critical industries, unlock new markets, and create a more sustainable, secure future.
Before Alumni Ventures, Matt was a two-time venture-backed founder/CEO and a leader of the innovation team at Nike. He founded Aurora Biofuels, a deep-tech venture that grew to 100+ employees and secured more than $100 million in funding before its acquisition by Reliance Industries. Earlier, he advised life science multinationals at Cambridge Pharma Consultancy (acquired by IMS Health) and gained experience on Bloomberg’s M&A team. Matt holds a BS in Biochemistry from Georgetown University and an MBA with a Certificate in Entrepreneurship from UC Berkeley.
Funds actively worked on
Investment Area of Focus
His investment lens favors bold solutions to global challenges and durable advantages rooted in technology and aligned with long-term megatrends. This translates to surgical robots powered by physical AI, next-generation energy systems, space-based infrastructure, longevity therapeutics, and more. The through-line is the potential for extraordinary value creation at the intersection of deep science and global need.
Representative investments Matt has led for Alumni Ventures include Andromeda Surgical and Cytronic (Physical AI); Arda Therapeutics and Cambrian Biopharma (Technologies for the Human Body); Max Space and Orbital Operations (Space Infrastructure); and Fortera and Mainspring Energy (The New Energy Stack). Alumni Ventures’ Deep Tech portfolio also includes companies such as Axiom Space, Ayar Labs, Cohere, Frore Systems, Groq, Hawkeye360, Hayden AI, Lambda, Radiant, and Rigetti (Nasdaq: RGTI).